Per Hertz Hansen

Title: Per Hertz Hansen: Innovator in Peptide and Insulin Derivatives

Introduction

Per Hertz Hansen is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of peptide and insulin derivatives. With a total of 6 patents to his name, Hansen's work has had a profound impact on medical science.

Latest Patents

Hansen's latest patents include innovative peptide derivatives that modify parent peptide hormones. These modifications involve introducing lipophilic substituents, which enhance the pharmacological activity and protracted profile of action of these hormones. Additionally, he has developed insulin derivatives that incorporate lipophilic groups, further improving their efficacy and duration of action.

Career Highlights

Throughout his career, Hansen has worked with prominent companies, including Novo Nordisk A/S. His expertise in peptide and insulin research has positioned him as a key figure in the pharmaceutical industry, contributing to advancements in drug development.

Collaborations

Hansen has collaborated with esteemed colleagues such as Ib Jonassen and Svend Havelund. These partnerships have fostered a collaborative environment that has led to innovative breakthroughs in his field.

Conclusion

Per Hertz Hansen's contributions to peptide and insulin derivatives exemplify his dedication to advancing pharmacological science. His innovative patents and collaborations continue to influence the industry and improve therapeutic outcomes.